產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-phospho-Cortactin (Tyr466)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-Cortactin (Tyr466)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-Cortactin (Tyr466)
Cat. Number:
Anti-phospho-Cortactin (Tyr466)抗體KL-3100R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene is overexpressed Anti-phospho-Cortactin (Tyr466)抗體in breast cancer and squamous cell carcinomas of the head and neck. The encoded protein is localized in the cytoplasm and in areas of the cell-substratum contacts. This gene has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, the encoded protein is degraded in a caspase-dependent manner. The aberrant regulation of this gene contributes to tumor cell invasion and metastasis. Three splice variants that encode different isoforms have been identified for this gene. [provided by RefSeq, May 2010]
Also known as:
Cortactin (phospho Tyr466); Anti-phospho-Cortactin (Tyr466)抗體Cortactin (phospho Y466); p-Cortactin (phospho Y466); Amplaxin; CTTN; EMS 1; EMS1; Mammary tumor and squamous cell carcinoma associated; Oncogene EMS1; p80/85 src substrate; Src substrate cortactin; SRC8_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Cortactin around the phosphorylation site of Tyr466(YAp-TEA).
●
Predicted Molecular Anti-phospho-Cortactin (Tyr466)抗體Weight: 61kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-phospho-Cortactin (Tyr466)抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-phospho-Cortactin (Tyr466)抗體must be determined by the end user.
kl469Hu01 內(nèi)皮脂肪酶(LIPG)多克隆抗體 Polyclonal Antibody to Likle, Endothelial (LIPG)
kl469Mu01 內(nèi)皮脂肪酶(LIPG)多克隆抗體 Polyclonal Antibody to Likle, Endothelial (LIPG)
kl469Ra01 內(nèi)皮脂肪酶(LIPG)多克隆抗體 Polyclonal Antibody to Likle, Endothelial (LIPG)
kl176Hu01 脂肪酶I(LIPI)多克隆抗體 Polyclonal Antibody to Likle I (LIPI)
kl176Mu01 脂肪酶I(LIPI)多克隆抗體 Polyclonal Antibody to Likle I (LIPI)
kl176Ra01 脂肪酶I(LIPI)多克隆抗體 Polyclonal Antibody to Likle I (LIPI)
kl175Hu01 脂肪酶H(LIPH)多克隆抗體 Polyclonal Antibody to Likle H (LIPH)
kl175Mu01 脂肪酶H(LIPH)多克隆抗體 Polyclonal Antibody to Likle H (LIPH)
kl386Hu01 脂蛋白脂酶(LIPD)多克隆抗體 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Mu01 脂蛋白脂酶(LIPD)多克隆抗體 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Ra01 脂蛋白脂酶(LIPD)多克隆抗體 Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl225Hu01 溶酶體酸脂肪酶A(LIPA)多克隆抗體 Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Mu01 溶酶體酸脂肪酶A(LIPA)多克隆抗體 Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Ra01 溶酶體酸脂肪酶A(LIPA)多克隆抗體 Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl526Ge01 脂多糖(LPS)多克隆抗體 Polyclonal Antibody to Lipopolysaccharide (LPS)
kl082Hu01 層粘連蛋白γ1(LAMγ1)多克隆抗體 Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Mu01 層粘連蛋白γ1(LAMγ1)多克隆抗體 Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Ra01 層粘連蛋白γ1(LAMγ1)多克隆抗體 Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl014Hu01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Mu01 骨成型蛋白4(BMP4)多克隆抗體 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
